Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2018

01-04-2018 | Research Article

Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice

Authors: Amir Sarayani, Mojgan Mashayekhi, Marzieh Nosrati, Zahra Jahangard-Rafsanjani, Mohammadreza Javadi, Navid Saadat, Sheyda Najafi, Kheirollah Gholami

Published in: International Journal of Clinical Pharmacy | Issue 2/2018

Login to get access

Abstract

Background Pharmacists’ interventions to improve outcomes of diabetes management have been promising. However, evidence on using telephone-based interventions in pharmacy practice are limited, particularly in developing countries. Objective To evaluate the efficacy of a telephone-based intervention to improve care and clinical outcomes in type-2 diabetes. Setting A referral community pharmacy and drug information center. Method We conducted a two-armed randomized controlled trial on 100 patients with type-2 diabetes. The intervention consisted of 16 telephone calls in 3 month by a trained pharmacist working in an academic drug information center, while the control group received usual care. Before random allocation, patients attended a live education session delivered by pharmacists to learn the basics of diabetes care and to confirm the eligibility criteria. Assessments were performed at baseline, month-3 (after intervention), and month-9 (follow-up). Main outcome measure Hemoglobin A1c (HbA1c). Results Eighty four patient completed the trial. Baseline variables were comparable between the two groups and the baseline value of hemoglobin A1c was 8.00 ± 1.44 in the study population. HbA1c was significantly improved in both groups at month-3 (6.97 ± 1.41 vs. 7.09 ± 1.78) and remained steady at month-9 (6.96 ± 1.44 vs. 7.26 ± 1.85). Lipid profile showed small improvements in the intervention group but was not significant. The adherence score and self-care score improvement was significantly higher in the intervention group at month-3 and were maintained at month-9. Conclusion Medication adherence and self-care significantly improved in the telephone-based intervention group. However, the improvement of clinical outcomes might have been diluted due to the live diabetes education session.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.CrossRefPubMed Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.CrossRefPubMed
2.
go back to reference Menke A, Rust KF, Fradkin J, Cheng YJ, Cowie CC. Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies. Ann Intern Med. 2014;161(5):328–35.CrossRefPubMed Menke A, Rust KF, Fradkin J, Cheng YJ, Cowie CC. Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies. Ann Intern Med. 2014;161(5):328–35.CrossRefPubMed
3.
go back to reference Hu H, Hori A, Nishiura C, Sasaki N, Okazaki H, Nakagawa T, et al. Hba1c, blood pressure, and lipid control in people with diabetes: Japan epidemiology collaboration on occupational health study. PLoS ONE. 2016;11(7):e0159071.CrossRefPubMedPubMedCentral Hu H, Hori A, Nishiura C, Sasaki N, Okazaki H, Nakagawa T, et al. Hba1c, blood pressure, and lipid control in people with diabetes: Japan epidemiology collaboration on occupational health study. PLoS ONE. 2016;11(7):e0159071.CrossRefPubMedPubMedCentral
4.
go back to reference Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013;36(8):2271–9.CrossRefPubMedPubMedCentral Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013;36(8):2271–9.CrossRefPubMedPubMedCentral
5.
go back to reference Feldman BS, Cohen-Stavi CJ, Leibowitz M, Hoshen MB, Singer SR, Bitterman H, et al. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes. PLoS ONE. 2014;9(9):e108145.CrossRefPubMedPubMedCentral Feldman BS, Cohen-Stavi CJ, Leibowitz M, Hoshen MB, Singer SR, Bitterman H, et al. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes. PLoS ONE. 2014;9(9):e108145.CrossRefPubMedPubMedCentral
6.
go back to reference Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013;12(1):57.CrossRefPubMedPubMedCentral Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013;12(1):57.CrossRefPubMedPubMedCentral
7.
go back to reference Paduch A, Kuske S, Schiereck T, Droste S, Loerbroks A, Sørensen M, et al. Psychosocial barriers to healthcare use among individuals with diabetes mellitus: a systematic review. Prim Care Diabetes. 2017;11(6):495–514.CrossRefPubMed Paduch A, Kuske S, Schiereck T, Droste S, Loerbroks A, Sørensen M, et al. Psychosocial barriers to healthcare use among individuals with diabetes mellitus: a systematic review. Prim Care Diabetes. 2017;11(6):495–514.CrossRefPubMed
8.
go back to reference Singh K, Ranjani H, Rhodes E, Weber MB. International models of care that address the growing diabetes prevalence in developing countries. Curr Diab Rep. 2016;16(8):69.CrossRefPubMed Singh K, Ranjani H, Rhodes E, Weber MB. International models of care that address the growing diabetes prevalence in developing countries. Curr Diab Rep. 2016;16(8):69.CrossRefPubMed
9.
go back to reference Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421–36.CrossRefPubMed Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421–36.CrossRefPubMed
10.
go back to reference Rothman R, Malone R, Bryant B, Horlen C, Pignone M. Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes. Am J Med Qual. 2003;18(2):51–8.CrossRefPubMed Rothman R, Malone R, Bryant B, Horlen C, Pignone M. Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes. Am J Med Qual. 2003;18(2):51–8.CrossRefPubMed
11.
go back to reference Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28(4):771–6.CrossRefPubMed Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28(4):771–6.CrossRefPubMed
12.
go back to reference Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci. 2011;16(1):43–9.PubMedPubMedCentral Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci. 2011;16(1):43–9.PubMedPubMedCentral
13.
go back to reference Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23(3):250–64.CrossRefPubMed Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23(3):250–64.CrossRefPubMed
14.
go back to reference Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, Saadat N, Rashidian A, Hadjibabaie M, et al. Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015;41(1):127–35.CrossRefPubMed Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, Saadat N, Rashidian A, Hadjibabaie M, et al. Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015;41(1):127–35.CrossRefPubMed
15.
go back to reference Collins C, Limone BL, Scholle JM, Coleman CI. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract. 2011;92(2):145–52.CrossRefPubMed Collins C, Limone BL, Scholle JM, Coleman CI. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract. 2011;92(2):145–52.CrossRefPubMed
16.
go back to reference Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev. 2013;2:CD010398. Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev. 2013;2:CD010398.
17.
go back to reference Angaran DM. Telemedicine and telepharmacy: current status and future implications. Am J Health Syst Pharm. 1999;56(14):1405–26.PubMed Angaran DM. Telemedicine and telepharmacy: current status and future implications. Am J Health Syst Pharm. 1999;56(14):1405–26.PubMed
18.
go back to reference Harris JE, Chen TC, Kim SB, Nguyen KL. Development of a pharmacist-managed, telephone-based tobacco-cessation clinic for veterans. Am J Health Syst Pharm. 2009;66(18):1610.CrossRefPubMed Harris JE, Chen TC, Kim SB, Nguyen KL. Development of a pharmacist-managed, telephone-based tobacco-cessation clinic for veterans. Am J Health Syst Pharm. 2009;66(18):1610.CrossRefPubMed
19.
go back to reference Hailey D, Roine R, Ohinmaa A. Systematic review of evidence for the benefits of telemedicine. J Telemed Telecare. 2002;8(suppl 1):1–7.PubMed Hailey D, Roine R, Ohinmaa A. Systematic review of evidence for the benefits of telemedicine. J Telemed Telecare. 2002;8(suppl 1):1–7.PubMed
20.
go back to reference Whitten PS, Mair FS, Haycox A, May CR, Williams TL, Hellmich S. Systematic review of cost effectiveness studies of telemedicine interventions. BMJ. 2002;324(7351):1434–7.CrossRefPubMedPubMedCentral Whitten PS, Mair FS, Haycox A, May CR, Williams TL, Hellmich S. Systematic review of cost effectiveness studies of telemedicine interventions. BMJ. 2002;324(7351):1434–7.CrossRefPubMedPubMedCentral
21.
go back to reference Holtz B, Lauckner C. Diabetes management via mobile phones: a systematic review. Telemed J E Health. 2012;18(3):175–84.CrossRefPubMed Holtz B, Lauckner C. Diabetes management via mobile phones: a systematic review. Telemed J E Health. 2012;18(3):175–84.CrossRefPubMed
22.
go back to reference Krishna S, Boren SA. Diabetes self-management care via cell phone: a systematic review. J Diabetes Sci Technol (Online). 2008;2(3):509–17.CrossRef Krishna S, Boren SA. Diabetes self-management care via cell phone: a systematic review. J Diabetes Sci Technol (Online). 2008;2(3):509–17.CrossRef
23.
go back to reference Nesari M, Zakerimoghadam M, Rajab A, Bassampour S, Faghihzadeh S. Effect of telephone follow-up on adherence to a diabetes therapeutic regimen. Jpn J Nurs Sci. 2010;7(2):121–8.CrossRefPubMed Nesari M, Zakerimoghadam M, Rajab A, Bassampour S, Faghihzadeh S. Effect of telephone follow-up on adherence to a diabetes therapeutic regimen. Jpn J Nurs Sci. 2010;7(2):121–8.CrossRefPubMed
24.
go back to reference Zolfaghari M, Mousavifar SA, Pedram S, Haghani H. The impact of nurse short message services and telephone follow-ups on diabetic adherence: which one is more effective? J Clin Nurs. 2012;21(13–14):1922–31.CrossRefPubMed Zolfaghari M, Mousavifar SA, Pedram S, Haghani H. The impact of nurse short message services and telephone follow-ups on diabetic adherence: which one is more effective? J Clin Nurs. 2012;21(13–14):1922–31.CrossRefPubMed
25.
go back to reference Wu L, Forbes A, Griffiths P, Milligan P, While A. Telephone follow-up to improve glycaemic control in patients with Type 2 diabetes: systematic review and meta-analysis of controlled trials. Diabet Med. 2010;27(11):1217–25.CrossRefPubMed Wu L, Forbes A, Griffiths P, Milligan P, While A. Telephone follow-up to improve glycaemic control in patients with Type 2 diabetes: systematic review and meta-analysis of controlled trials. Diabet Med. 2010;27(11):1217–25.CrossRefPubMed
26.
go back to reference Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):834–40.CrossRefPubMed Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):834–40.CrossRefPubMed
27.
go back to reference Saheb Sharif-Askari F, Saheb Sharif-Askari N, Javadi M, Gholami K. Adverse drug reactions reported to the drug and poison information center of Tehran. Iran. PLoS One. 2017;12(9):e0185450.CrossRefPubMed Saheb Sharif-Askari F, Saheb Sharif-Askari N, Javadi M, Gholami K. Adverse drug reactions reported to the drug and poison information center of Tehran. Iran. PLoS One. 2017;12(9):e0185450.CrossRefPubMed
28.
go back to reference Gholami K, Kamalinia G, Ahmadian Attari MM, Salamzadeh J. Three years evaluation of drug shortages from educational pharmacies in tehran. Iran J Pharm Res. 2012;11(2):565–72.PubMedPubMedCentral Gholami K, Kamalinia G, Ahmadian Attari MM, Salamzadeh J. Three years evaluation of drug shortages from educational pharmacies in tehran. Iran J Pharm Res. 2012;11(2):565–72.PubMedPubMedCentral
29.
go back to reference Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–54.CrossRef Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–54.CrossRef
30.
go back to reference Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–50.CrossRefPubMed Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–50.CrossRefPubMed
31.
go back to reference Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ispor task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104.CrossRefPubMed Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ispor task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104.CrossRefPubMed
32.
go back to reference Suksomboon N, Poolsup N, Nge YL. Impact of phone call intervention on glycemic control in diabetes patients: a systematic review and meta-analysis of randomized, controlled trials. PLoS ONE. 2014;9(2):e89207.CrossRefPubMedPubMedCentral Suksomboon N, Poolsup N, Nge YL. Impact of phone call intervention on glycemic control in diabetes patients: a systematic review and meta-analysis of randomized, controlled trials. PLoS ONE. 2014;9(2):e89207.CrossRefPubMedPubMedCentral
33.
go back to reference Krass I, Armour C, Mitchell B, Brillant M, Dienaar R, Hughes J, et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007;24(6):677–83.CrossRefPubMed Krass I, Armour C, Mitchell B, Brillant M, Dienaar R, Hughes J, et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007;24(6):677–83.CrossRefPubMed
34.
go back to reference Fera T, Bluml BM, Ellis WM. Diabetes ten city challenge: final economic and clinical results. J Am Pharm Assoc. 2009;49(3):383–91.CrossRef Fera T, Bluml BM, Ellis WM. Diabetes ten city challenge: final economic and clinical results. J Am Pharm Assoc. 2009;49(3):383–91.CrossRef
35.
go back to reference American-Diabetes-Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Suppl 1):S11–S66. American-Diabetes-Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Suppl 1):S11–S66.
36.
go back to reference American-Diabetes-Association. 9. Cardiovascular disease and risk management. Diabetes Care. 2017;40(Supplement 1):S75–S87. American-Diabetes-Association. 9. Cardiovascular disease and risk management. Diabetes Care. 2017;40(Supplement 1):S75–S87.
37.
go back to reference Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109.CrossRefPubMed Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109.CrossRefPubMed
38.
go back to reference Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833):2252–61.CrossRefPubMed Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833):2252–61.CrossRefPubMed
39.
go back to reference Piette JD, Weinberger M, Kraemer FB, McPhee SJ. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a department of veterans affairs health care system. Diabetes Care. 2001;24(2):202–8.CrossRefPubMed Piette JD, Weinberger M, Kraemer FB, McPhee SJ. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a department of veterans affairs health care system. Diabetes Care. 2001;24(2):202–8.CrossRefPubMed
40.
go back to reference Miguel A, Hall A, Liu W, Garrett J, Ballew A, Yang TH, et al. Improving comprehensive medication review acceptance by using a standardized recruitment script: a randomized control trial. J Manag Care Spec Pharm. 2017;23(1):13–21.CrossRefPubMed Miguel A, Hall A, Liu W, Garrett J, Ballew A, Yang TH, et al. Improving comprehensive medication review acceptance by using a standardized recruitment script: a randomized control trial. J Manag Care Spec Pharm. 2017;23(1):13–21.CrossRefPubMed
Metadata
Title
Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice
Authors
Amir Sarayani
Mojgan Mashayekhi
Marzieh Nosrati
Zahra Jahangard-Rafsanjani
Mohammadreza Javadi
Navid Saadat
Sheyda Najafi
Kheirollah Gholami
Publication date
01-04-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 2/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0593-0

Other articles of this Issue 2/2018

International Journal of Clinical Pharmacy 2/2018 Go to the issue